Pricing Log in Create free account

PDS Biotechnology Corporation (PDSB) vs Spruce Biosciences, Inc. (SPRB)

PDS Biotechnology Corporation and Spruce Biosciences, Inc. are both Biotechnology companies. PDS Biotechnology Corporation and Spruce Biosciences, Inc. are of similar size ($133.8M and $129.2M). Across the 9 metrics below, Spruce Biosciences, Inc. leads on 5 and PDS Biotechnology Corporation on 4.

Valuation

Metric PDSB SPRB Biotechnology median
P/E n/m n/m 10.60
P/S n/m 23.04 9.40
P/B n/m 1.35 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 4.88 9.02
Earnings yield (52.03%) (88.60%) (32.88%)
Free cash flow yield (24.15%) (37.80%) (23.13%)

Profitability

Metric PDSB SPRB Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (543.97%) (105.98%) (51.96%)
Return on assets (136.65%) (82.38%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PDSB SPRB Biotechnology median
Revenue growth (TTM) — (51.32%) 6.76%
EPS growth (last fiscal year) 28.16% 47.59% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PDSB SPRB Biotechnology median
Debt to equity (1.21) 0.08 0.00
Current ratio 0.57 9.23 4.97
Net debt to EBITDA 0.50 1.34 1.01

Dividend

Metric PDSB SPRB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PDSB SPRB Biotechnology median
Market cap 129.16m 133.79m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack